Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Phenomenex Chiral Screening Services Now Offered in China

Published: Wednesday, December 05, 2012
Last Updated: Wednesday, December 05, 2012
Bookmark and Share
Collaboration with Chinese Academy of Sciences ensures fast, high-quality screening.

Phenomenex Inc. has announced the extension of its Chiral Screening Service to pharmaceutical and natural products customers in China.

The service is offered in collaboration with the Chinese Academy of Sciences (CAS), a leading academic and R&D center under which the Shanghai Institute of Organic Chemistry (SIOC) has developed a strong chiral team that works closely with Phenomenex.

The free Chiral Screening Service provides target screening using a library of HPLC columns including the Phenomenex Lux™ polysaccharide-based offerings, which demonstrate a success rate approaching 90 percent.

After resolving the chiral compound, Phenomenex delivers a method development and optimization plan to the customer within 10 business days - the same rapid turnaround the service promises in the U.S. and Europe.

“Our customer base in China has been growing rapidly and the expansion of our services will help us better serve them,” explains Michael Klein, brand manager for Phenomenex. “By teaming up with the CAS-SIOC, we are able to quickly roll out our rapid-response service.”

Enantiomers of chiral compounds may have different pharmacological effects in biological systems and they must be identified and evaluated separately.

“Resolving chiral compounds is relatively difficult, and column selection can be complicated,” continues Klein. “Our Chiral Screening Service eliminates time-consuming guesswork and also gives customers a chance to ‘test-drive’ our Lux columns.”

The Phenomenex team of chiral experts will customize a plan for each screening project, taking into account specific requirements and overall separation goals.

Once a project is completed, the customer will receive a report that details the optimal method including information on the chiral stationary phase (CSP) selected for the separation, running conditions and associated chromatograms.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Phenomenex Launches Spin-Off Technology Company Neoteryx LLC
Company will be spinning off a biological sampling focused company named Neoteryx LLC.
Saturday, July 19, 2014
Phenomenex Launches Newsletter for Food Chemists
The Dish is a regular newsletter specially written for the food testing industry.
Tuesday, April 15, 2014
Phenomenex Phree™ Phospholipid Removal Plates Win R&D 100 Award
Winners will be recognized at the R&D 100 Awards Banquet on November 7.
Monday, July 15, 2013
Phenomenex CEO Receives the Ellis Island Medal of Honor
Fasha Mahjoor was presented with an Ellis Island Medal of Honor, which ranks among the United States’ most prestigious awards.
Thursday, May 16, 2013
Phenomenex to Host AACC Workshop on LC/MS/MS for Clinical Diagnostics
Two-day, hands-on program to be held May 15 and 16.
Friday, May 10, 2013
Phenomenex Serves Growing Korean Market with Translated Website
Site also introduces a new industry-focused interface to help customers quickly find the best columns and methods for their needs.
Tuesday, May 07, 2013
Phenomenex Expert Selected to Present on Residues and Contaminants in Food
United Nations Agencies Fund Initiative to improve food safety in developing countries.
Wednesday, April 24, 2013
Phenomenex Launches Environmental Edge Newsletter
Environmental Edge newsletter will provide useful information on industry trends and tips.
Monday, April 08, 2013
Phenomenex Launches Innovative, Industry-Focused Websites
Company builds on award-winning web presence with new digital experience.
Friday, February 22, 2013
Phenomenex to Present Four Workshops at Pittcon 2013
Workshops will cover proteins, environmental contaminants, oligonucleotide therapeutics and core-shell technology.
Monday, December 17, 2012
Phenomenex and ChromaDex® Announces Collaboration Agreement
New solutions to be presented at Association of Analytical Communities annual meeting next week.
Wednesday, October 03, 2012
Phenomenex Forms Phenova - A Certified Reference Materials Company
New company culminates the integration and expansion of Colorado-based Wibby Environmental.
Friday, August 24, 2012
Phenomenex Celebrates 30 Years
The company has grown from a one-man operation out of a garage to over 700 employees and a network of partners in 95 countries in only three decades.
Wednesday, June 13, 2012
Phenomenex Announces Direct Sales and Service for Sweden
Company expands its international team to serve Sweden.
Monday, January 30, 2012
Workshops on Biofuels Analysis and New Applications for UHPLC
Phenomenex Inc. will be presenting two workshops at Pittcon 2012 in Orlando.
Monday, January 09, 2012
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!